SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-21-000032
Filing Date
2021-03-10
Accepted
2021-03-10 16:41:28
Documents
6

Document Format Files

Seq Description Document Type Size
1 MODERNA, INC. - DEFA14A lmrna2021_defa14a.htm DEFA14A 12745
2 GRAPHIC box1.jpg GRAPHIC 1082
3 GRAPHIC checkbox1.jpg GRAPHIC 1317
4 GRAPHIC im2140623574x1773569987.jpg GRAPHIC 28148
5 GRAPHIC lmrna_prxy1.jpg GRAPHIC 335176
6 GRAPHIC lmrna_prxy2.jpg GRAPHIC 241658
  Complete submission text file 0001308179-21-000032.txt   850961
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38753 | Film No.: 21730384
SIC: 2836 Biological Products, (No Diagnostic Substances)